11123331

4 known cases. View patent page →

Cases
4
Active
4
0 closed
Filed
2022–2026
Top venue
D. Delaware
2 cases

Filing activity

2022: 1 case1'22'232024: 1 case'24'252026: 1 case'26
Cases asserting US Patent 11123331 filed per year.

Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. et al.

active
Docket:
1:22-cv-00909
Filed:
2022-07-07
Patents:11123331

Veloxis Pharmaceuticals, Inc. filed suit alleging patent infringement due to the defendants' submission of Abbreviated New Drug Applications (ANDA) for generic tacrolimus extended-release tablets. Veloxis is seeking favorable judgment, an order preventing manufacturing, and damages.

Untitled case

active
Docket:
1:24-cv-00726
Patents:11123331

This is an active litigation case in the Delaware District Court involving US Patent 11,123,331.